Position in BLLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,034,658
+$320,996 QoQ
Shares Held
89,114
+8.6% QoQ
Ownership
0.194%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $15,360,896,443 across 43 Diagnostics & Research names. BLLN ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
8,407,891 | $4,132,730,662 | |
| 2 | DHR |
Danaher Corp /De/
|
14,145,758 | $2,682,035,716 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
2,660,999 | $1,495,188,727 | |
| 4 | A |
Agilent Technologies, Inc.
|
7,522,028 | $857,360,751 | |
| 5 | WAT |
Waters Corp /De/
|
2,646,458 | $788,115,192 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
605,739 | $763,958,026 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
4,463,052 | $761,128,887 | |
| 8 | DGX |
Quest Diagnostics Inc
|
3,086,308 | $604,854,641 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,034,658 | 89,114 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,713,662 | 82,034 | Shares | Defined | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||